Pro Bono Bio - Antibacterial's Unit Acquisition

Pro Bono Bio - Antibacterial raised a round of funding on January 31, 2017. Investors include Spero Therapeutics.

Pro Bono Bio specializes in nano-lipid, healthcare technology with a focus on pain, haematology and dermatology.…

Articles about Pro Bono Bio - Antibacterial's Unit Acquisition: